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Lactic acidosis is one of the metabolic acidoses with increased anion gap. Lactic
acidosis is defined as pH ≤ 7.35 and plasma lactate concentration ≥ 5 meq/L.
1
There are two types of lactic acidosis. Type B occurs in malignancy, diabetes
mellitus, renal or hepatic failure, severe infection, and drugs, whereas type A is
caused by apparent tissue ischemia, as in shock, severe anemia, mitochondrial
enzyme defects, and inhibitors such as carbon monoxide and cyanide.
2 Lactic
acidosis is a rare and often overlooked condition, but is associated with high
mortality, because of advanced disease process and high tumor burden. We report
a case of a 39-year-old man with recurred leukemia who presented with lactic
acidosis.
A 39-year-old man visited an emergency room because of dyspnea for 1 week.
Seventeen years prior to admission, he was diagnosed with acute lymphoid
leukemia in another hospital. One year ago, he was admitted to this hospital with
general weakness, and a bone marrow biopsy showed leukemia recurrence. The
bone marrow biopsy revealed acute pre-B cell acute lymphoblastic leukemia
(ALL), group II with aberrant expression of CD33. Upon fluorescence in situ
hybridization, p16 (CEP9) deletion on chromosome 9p21 was detected. After re-
induction chemotherapy with vincristine, prednisolone, daunorubicin, and L-
asparaginase (VPDL), he achieved a hematological but not a cytogenetic res-
ponse. Upon admission, no specific sign was present except tachypnea, (respiratory
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Type B lactic acidosis is a rare condition in patients with solid tumors or hematological malignancies. Although
there have been several theories to explain its mechanism, the exact cause of lactic acidosis remains to be disco-
vered. Lactic acidosis is usually related to increased tumor burden in patients with malignancy. We experienced a
case of lactic acidosis in a 39-year-old man who visited an emergency room because of dyspnea, and the cause of
lactic acidosis turned out to be recurrent acute leukemia. Chemotherapy relieved the degree of lactic acidosis
initially, but as the disease progressed, lactic acidosis became aggravated. Type B lactic acidosis can be a clinical
presentation of acute exacerbation of acute leukemia.
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INTRODUCTION
CASE REPORTrate 36 breaths/min). Blood pressure was 120/70 mmHg,
pulse rate was 100 bpm, and body temperature was 36.9˚C.
No hepatomegaly was noted.
Laboratory data showed pH 7.206, PaCO2 11.7 mmHg,
PaO2 131.3 mmHg, bicarbonate 4.5 mmol/L, and base
excess -21.1. Serum sodium was 133 mEq/L, potassium
4.1 mEq/L, chloride 102 mEq/L, and the anion gap was
19.3 mEq/L. The complete blood cell count showed a white
blood cell of 3,200/µL, hemoglobin 9.6 g/dL, and platelet
count of 83,000/µL. The differential count showed 61%
neutrophils, 27% lymphocytes, 11% immature cells, 1%
band neutrophils, and no basophils, eosinophils or
monocytes. The coagulation profile was within the normal
range. Blood chemistry showed 17 mg/dL blood urea
nitrogen, 0.8 mg/dL creatinine, 4.5 g/dL albumin, 8 IU/L
aspartate aminotransferase, 5 IU/L alanine aminotrans-
ferase, 0.67 mg/dL total bilirubin, and 302 IU/L lactate
dehydrogenase. C-reactive protein was 1.34 mg/dL. The
random plasma glucose level in the emergency room was
179 mg/dL. Peripheral blood morphology examination
showed 20% blasts with some spherocytes and tear drop
cells. Serum thiamine level was 18.60 ng/mL (normal
range, 21.3-81.9 ng/mL). A chest radiography showed no
active infiltrative lesions.
Continuous bicarbonate replacement therapy was per-
formed to maintain cardiovascular stability. Arterial blood
gas analysis improved to pH 7.346, PaCO2 20.1 mmHg,
PaO2 135.2 mmHg, H CO3
- 10.7 mmol/L, and base excess
of  -12.3 mmol/L. The blood lactate level was not checked
in the emergency room. On day 3 of admission, a bone
marrow biopsy was performed, and the result showed that
ALL was sustained. Re-induction chemotherapy with vin-
cristine and prednisone (VP) regimen was started imme-
diately. Lactate was 11.6 mmol/L on day 2 of chemothe-
rapy. After 3 weeks, lactate level decreased to 4.6 mmol/L.
After finishing the chemotherapeutic schedule, leukemic
blasts still showed on the follow-up bone marrow exami-
nation, and the number and percentage of blast cells in the
peripheral blood started to increase. As the number of
immature cells in peripheral blood increased, the lactic
acid began to increase again. The serum lactic acid level
fluctuated from 12 to 20 mmol/L, regardless of bicarbo-
nate replacement. However, the patient was asymptomatic
and blood pH remained neutral without bicarbonate repla-
cement therapy. On day 147 of admission, the patient
expired as a result of disease progression combined with
uncontrolled infection.
Lactic acid is a degradation product of glucose in anaerobic
conditions. After glycolysis, pyruvate is converted to acetyl-
coenzyme A (CoA) to form energy in the Krebs cycle in
aerobic conditions. However, in anaerobic conditions,
pyruvate is converted to lactate. Lactate is normally formed
in skeletal muscle, red blood cells, and the brain, and its
amount is usually less than 1,500 mmol/day. It is meta-
bolized to form water and carbon dioxide in liver and
kidneys. Lactic acidosis results from an imbalance of
formation and degradation of lactic acid.
3
More frequent causes of lactic acidosis in patients with
malignancy are heart failure, sepsis, and decreased effective
circulating volume, and these result in type A lactic acidosis.
Type B lactic acidosis in malignancy was first reported in
1963, in an acute leukemia patient.
4 In Korea, a case of
lactic acidosis in a patient with leukemia transformed from
lymphoma was reported in 1999,
5 and a case of lactic aci-
dosis due to thiamine deficiency was reported in 2007.
6
The present case did not have any signs of infection,
hypoxia, or circulatory failure. The mechanism of type B
lactic acidosis in malignancy is unidentified, but it may be
caused by tumor microembolism, increased glycolysis, and
decreased gluconeogenesis by abnormal tumor metabolism,
or decreased degradation of lactic acid because of extensive
liver involvement. Tumor necrosis factor-αis thought to play
a role by reducing the activity of pyruvate dehydrogenase,
which converts pyruvate to acetyl-CoA.
7 It also inhibits the
cytochrome-dependent electron transport system and in-
creases anaerobic glycolysis.
7 Lactic acid is metabolized
mainly in the liver and kidneys. The liver contributes to
90% of lactate metabolism and is frequently involved in
patients with lactic acidosis.
8-10 In the present case, there
was no evidence of liver involvement. Thiamine deficiency
is also known to be a cause of lactic acidosis,
11 but this
patient was refractory to thiamine replacement.
Treatment of the primary condition, such as chemothe-
rapy in malignancy, remains the mainstay of treatment.
1
Treatment with renal replacement therapy is controversial.
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Fig. 1. Change of blood lactic acid level after chemotherapy. Blood lactic acid
level decreased as the patient responded to chemotherapy.In 2001, Sillos, et al.
1 reported a case of lactic acidosis in
an 11-year-old girl with acute lymphoblastic leukemia.
Blood pH improved rapidly after continuous veno-venous
hemofiltration, but her plasma lactate concentration con-
tinued to increase. It decreased after chemotherapy began
to take effect.
In patients with metabolic acidosis of unknown origin,
lactic acidosis should be considered. Serum lactic acid
levels should be checked in cases of metabolic acidosis
with increased anion gap. Leukemia usually presents as a
fever, infection, and bleeding tendency, with lactic acidosis
as a rare presentation. Physicians should be aware of lactic
acidosis in recurring or advanced malignancy, and treat-
ment of the underlying disease should be performed imme-
diately.
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